Perflubron - LiquiVent
Alternative Names: LiquiVentLatest Information Update: 29 May 2001
At a glance
- Originator Alliance Pharmaceutical Corporation
- Class Fluorocarbons; Small molecules
- Mechanism of Action Cell membrane permeability enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Acute lung injury; Adult respiratory distress syndrome; Neonatal respiratory distress syndrome; Respiratory tract disorders
Most Recent Events
- 29 May 2001 Discontinued-III for Acute lung injury in Canada (Intrapulmonary)
- 29 May 2001 Discontinued-III for Acute lung injury in Europe (Intrapulmonary)
- 29 May 2001 Discontinued-III for Acute lung injury in USA (Intrapulmonary)